Nissan Motor will cut production of its top-selling Rogue SUV in Japan from next week due to a short supply of chips from Dutch firm Nexperia, according to a person familiar with the matter, the latest fallout from the diplomatic turmoil involving the chipmaker.
Nissan plans to cut output of the Rogue sport-utility vehicle by about 900 vehicles in the week starting November 10 at its plant in southwestern Kyushu, said the person, who declined to be identified because the information is not public.
The automaker is also reviewing planned output for the plant for the week of November 17 as the supply of parts using Nexperia chips remains impacted, the person said.
The Rogue, sold as the X-Trail in Japan and Britain, was Nissan's top-selling model in the United States last year at almost 246,000 vehicles. Nissan also makes Rogue models at Smyrna in the U.S. state of Tennessee.
In a statement to Reuters, Nissan said it would implement "small-scale production adjustments" during the week of November 10 involving several hundred vehicles at the Kyushu plant and its Oppama plant, south of Tokyo, where it makes the Note compact.
It said the situation remained fluid and it was monitoring developments closely. "Once supply stabilises, we will recover quickly and ensure any impact on customer deliveries is minimised," it said.
Further details will be shared at second-quarter earnings on Thursday, Nissan said.
Automakers worldwide are scrambling to deal with the supply squeeze linked to Nexperia, which is hitting production and has caused some firms to furlough staff.
China banned exports of Nexperia products after the Dutch government seized control of the firm in September, citing fear of technology transfers to its Chinese parent, Wingtech , which the United States has flagged as a potential security risk.
Nissan plans to cut output of the Rogue sport-utility vehicle by about 900 vehicles in the week starting November 10 at its plant in southwestern Kyushu, said the person, who declined to be identified because the information is not public.
The automaker is also reviewing planned output for the plant for the week of November 17 as the supply of parts using Nexperia chips remains impacted, the person said.
The Rogue, sold as the X-Trail in Japan and Britain, was Nissan's top-selling model in the United States last year at almost 246,000 vehicles. Nissan also makes Rogue models at Smyrna in the U.S. state of Tennessee.
In a statement to Reuters, Nissan said it would implement "small-scale production adjustments" during the week of November 10 involving several hundred vehicles at the Kyushu plant and its Oppama plant, south of Tokyo, where it makes the Note compact.
It said the situation remained fluid and it was monitoring developments closely. "Once supply stabilises, we will recover quickly and ensure any impact on customer deliveries is minimised," it said.
Further details will be shared at second-quarter earnings on Thursday, Nissan said.
Automakers worldwide are scrambling to deal with the supply squeeze linked to Nexperia, which is hitting production and has caused some firms to furlough staff.
China banned exports of Nexperia products after the Dutch government seized control of the firm in September, citing fear of technology transfers to its Chinese parent, Wingtech , which the United States has flagged as a potential security risk.
